PAPER
Carboxylate Derivatives of Oligopyridines
MS (Maldi-TOF): m/z = 305.
1141
Anal. calcd for C8H7Br2NO2: C, 31.10; H, 2.28; N, 4.53. Found: C,
30.99; H, 2.43; N, 4.42.
Anal. calcd for C18H15N3O2•H2O: C, 66.86; H, 5.30; N, 12.99.
Found: C, 67.11; H, 5.55; N, 13.11.
Stille Coupling Reactions; General Procedure
Ethyl 5,5’’-Dimethyl-2,2’:6’,2’’-terpyridine-4’-carboxylate (11)
Dibromo compound 3 (1 mol), stannyl compounds 6, 7 and 14, re-
spectively, (1 or 2 equiv) and (Ph3Ph)4Pd (0.01 or 0.02 equiv) were
heated under N2 in toluene (50 mL) for 16 h. Upon cooling to r.t. aq
sat. NH4Cl solution (20 mL) was added. The mixture was stirred for
further 30 min and then filtered over Celite. The precipitate was
washed with CH2Cl2 (50 mL) and the organic phase was separated.
The aqueous phase was extracted with toluene (3 × 25 mL). The
combined organic phases were dried (MgSO4) and the solvent was
removed. Concd HCl (30 mL) was added to the residue and extract-
ed with CH2Cl2 (3 × 30 mL). The aqueous phase was cautiously
neutralized by solid NaOH. The oligopyridines were then extracted
with CH2Cl2 (3 ¥ 30 mL) and dried (MgSO4). The solvent was re-
moved and the product purified by chromatography on silica gel
with CH2Cl2/hexane (1:2) as eluent. Oligopyrindine carboxylic ac-
ids which are not soluble in CH2Cl2 were filtered and purified by
chromatography on silica gel with MeOH.
Mp 169-170 °C.
IR (KBr): n = 1721s, 1562m, 1480m, 1374m, 1261s, 1234m, 849m,
777m cm-1.
1H NMR (CDCl3): d = 8.92 (s, H-3’, 2 H), 8.58 (d, J = 1.95 Hz,
H-6, 2 H), 8.53 (d, J = 7.80 Hz, H-3, 2 H), 7.87 (dd, J = 7.80, 1.95
Hz, H-4, 2 H), 4.47 (q, J = 6.90 Hz, CH2, 2 H), 2.44 (s, CH3, 6 H),
1.54 (t, J = 6.90 Hz, CH3, 3 H).
13C NMR (CDCl3): d = 165.42, 156.43, 152.95, 149.61, 139.85,
137.28, 133.71, 120.73, 119.58, 61.59, 18.39, 14.27.
MS (Maldi-TOF): m/z = 333.
Anal. calcd for C20H19N3O2•1.5H2O: C, 70.16; H, 5.89; N, 12.27.
Found: C, 70.64; H, 6.01; N, 12.26.
Ethyl 2,6-dibromopyridine-4-carboxylate (3; 0.40 g, 1.29 mmol) re-
acted with 6 (1 equiv) to give 0.075 g (20%) 12 and 0.15 g (38%) 13.
Ethyl 2,6-dibromopyridine-4-carboxylate (3; 0.50 g, 1.62 mmol) re-
acted with 6 (2 equiv) to give 0.21 g (54%) of 8 and 0.17 g (34%)
of 9.
6-Bromo-2,2’-bipyridine-4-carboxylic Acid (12)
Mp 203-204 °C.
IR (KBr): n = 3386br, 1609m, 1588m, 1540s, 1397s, 1366m, 780m,
2,2’:6’,2’’-Terpyridine-4’-carboxylic Acid (8)
Mp 280-282 °C.
733m cm-1.
1H NMR (CD3OD): d = 8.76 (s, H-3, 1 H), 8.65 (d, J = 7.80 Hz,
H-6’, 1 H), 8.33 (d, J = 7.80 Hz, H-3’, 1 H), 7.96 (s, H-5, 1 H), 7.94
(ddd, J = 8.30, 7.80, 1.95 Hz, H-4’, 1 H), 7.45 (ddd, J = 8.30,
7.80, 1.95 Hz, H-5’, 1 H).
13C NMR (CD3OD): d = 170.96, 158.57, 155.92, 151.21, 150.41,
142.79, 138.59, 128.77, 125.61, 122.64, 120.90.
IR (KBr): n = 3400br, 1625m, 1592m, 1555m, 1473m, 1401s, 777m
cm-1.
1H NMR (CD3OD): d = 8.82 (s, H-3’, 2 H), 8.68 (d, J = 7.80 Hz, H-
6, 2 H), 8.57 (d, J = 7.80 Hz, H-3, 2 H), 7.98 (ddd, J = 8.30, 7.80,
1.95 Hz, H-4, 2 H), 7.46 (ddd, J = 8.30, 7.80, 1.95 Hz, H-5, 2 H).
13C NMR (CD3OD): d = 173.01, 157.46, 157.14, 150.26, 149.72,
138.62, 125.26, 122.84, 121.87.
MS (Maldi-TOF): m/z = 279.
Anal. calcd for C11H7BrN2O2•2.75H2O: C, 40.20; H, 3.83; N, 8.52.
Found: C, 40.06; H, 3.06; N, 8.22.
MS (Maldi-TOF): m/z = 277.
Anal. calcd for C16H11N3O2•H2O: C, 65.08; H, 4.44; N, 14.23.
Found: C, 65.61; H, 4.65; N, 14.02.
Ethyl 6-Bromo-2,2’-bipyridine-4-carboxylate (13)
Mp 169-170 °C.
Ethyl 2,2’:6’,2’’-Terpyridine-4’-carboxylate (9)
IR (KBr): n = 2980m, 1731s, 1585s, 1543s, 1480m, 1387s, 1364m,
Mp 133.5 °C.
1300m, 1260s, 1225s, 1147m, 1112m, 1021m, 766m cm-1.
IR (KBr): n = 2991m, 1725s, 1584m, 1536m, 1466m, 1396s,
1H NMR (CDCl3): d = 8.86 (s, H-3, 1 H), 8.68 (d, J = 7.80 Hz,
H-6’, 1 H), 8.38 (d, J = 7.80 Hz, H-3’, 1 H), 8.02 (s, H-5, 1 H), 7.81
(ddd, J = 8.30, 7.80, 1.95 Hz, H-4’, 1 H), 7.33 (ddd, J = 8.30, 7.80,
1.95 Hz, H-5’, 1 H), 4.43 (q, J = 6.90 Hz, CH2, 2 H), 1.40 (t,
J = 6.90 Hz, CH3, 3 H).
13C NMR (CDCl3): d = 163.82, 153.75, 149.30, 141.96, 141.13,
137.02, 130.83, 127.38, 124.58, 121.58, 119.18, 62.16, 14.21.
1370m, 1259s, 1237s, 1024m, 764m, 732m cm-1.
1H NMR (CDCl3): d = 8.97 (s, H-3’, 2 H), 8.74 (d, J = 7.80 Hz,
H-6, 2 H), 8.61 (d, J = 7.80 Hz, H-3, 2 H), 7.87 (ddd, J = 8.30, 7.80,
1.95 Hz, H-4, 2 H), 7.36 (ddd, J = 8.30, 7.80, 1.95 Hz, H-5, 2 H),
4.47 (q, J = 6.90 Hz, CH2, 2 H), 1.54 (t, J = 6.90 Hz, CH3, 3 H).
13C NMR (CDCl3): d = 165.36, 156.49, 155.49, 149.30, 140.13,
136.91, 124.09, 121.30, 120.35, 61.76, 14.35.
MS (Maldi-TOF): m/z = 307.
MS (Maldi-TOF): m/z = 305.
Anal. calcd for C13H11BrN2O2: C, 50.84; H, 3.61; N, 9.12. Found:
C, 51.21; H, 3.58; N, 9.19.
Anal. calcd for C18H15N3O2: C, 70.81; H, 4.95; N, 13.76. Found: C,
70.58; H, 5.23; N, 13.69.
Ethyl 2,6-dibromopyridine-4-carboxylate (3; 0.50 g, 1.62 mmol) re-
acted with 14 (2 equiv) to give 0.145 g (22%) 15 and 0.17 g (24%)
16.
Ethyl 2,6-dibromopyridine-4-carboxylate (3; 0.50 g, 1.62 mmol) re-
acted with 7 (2 equiv) to give 0.12 mg (24%) 10 and 0.20 g (37%)
11.
2,2’:6’,2’’:6’’,2’’’:6’’’,2’’’’-Quinquepyridine-4’’-carboxylic Acid
(15)
Mp 250-252 °C.
5,5’’-Dimethyl-2,2’:6’,2’’-terpyridine-4’-carboxylic Acid (10)
Mp 245-246 °C.
IR (KBr): n = 3360br, 1648m, 1616s, 1537s, 1488m, 1404s, 1378s,
IR (KBr): n = 3370br, 1627m, 1581m, 1538s, 1401s, 1364m, 779s,
794m, 730s cm-1.
751m cm-1.
1H NMR (CD3OD): d = 8.74 (s, H-3’, 2 H), 8.51 (br s, H-6, 2 H),
8.46 (d, J = 7.80 Hz, H-3, 2 H), 7.78 (d, J = 7.80 Hz, H-4, 2 H), 2.43
(s, CH3, 6 H).
13C NMR (CD3OD): d = 171.04, 157.06, 150.72, 138.99, 135.37,
128.37, 122.41, 122.24, 121.27, 18.26.
1H NMR (CD3OD): d = 9.05 (s, H-3’’, 2 H), 8.85 (d, J = 7.80 Hz,
2 H), 8.76 (t, J = 7.80 Hz, H-4’, 2 H), 8.66 (m, 2 H), 8.41 (d,
J = 7.80 Hz, 2 H), 8.05 (ddd, J = 8.30, 7.80, 1.95 Hz, H-4, 2 H), 8.02
(d, J = 7.80 Hz, 2 H), 7.47 (ddd, J = 8.30, 7.80, 1.95 Hz, H-5, 2 H).
Synthesis 2000, No. 8, 1138–1142 ISSN 0039-7881 © Thieme Stuttgart · New York